Drug Shortage Report for PDP-DESONIDE
Report ID | 150021 |
Drug Identification Number | 02229315 |
Brand name | PDP-DESONIDE |
Common or Proper name | PDP-DESONIDE |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | DESONIDE |
Strength(s) | 0.05% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 15g |
ATC code | D07AB |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-26 |
Estimated end date | Unknown |
Actual end date | 2024-07-15 |
Shortage status | Resolved |
Updated date | 2024-07-16 |
Company comments | PDP-DESONIDE available in 60g cream and 60g ointment formats |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-07-16 | English | Compare |
v5 | 2024-07-15 | French | Compare |
v4 | 2024-07-15 | English | Compare |
v3 | 2021-11-27 | English | Compare |
v2 | 2021-11-26 | French | Compare |
v1 | 2021-11-26 | English | Compare |
Showing 1 to 6 of 6